BioCentury
ARTICLE | Company News

AbCheck, Eli Lilly deal

October 11, 2010 7:00 AM UTC

AbCheck will use its three antibody libraries to discover antibodies against targets selected by Eli Lilly, which will have rights to any antibodies discovered. AbCheck will receive discovery fees and...